Lower rates of hypoglycaemia in older individuals with type 2 diabetes using insulin degludec versus insulin glargine U100: Results from SWITCH 2

AIM: This study aimed to investigate the safety of insulin degludec (degludec) in relation to age and risk of hypoglycaemia post hoc in individuals with type 2 diabetes (T2D) (SWITCH 2 trial). METHODS: In this crossover study, individuals with T2D who were at risk of hypoglycaemia were randomized to...

Descripción completa

Detalles Bibliográficos
Autores principales: Heller, Simon R., DeVries, J. Hans, Wysham, Carol, Hansen, Charlotte T., Hansen, Melissa V., Frier, Brian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618254/
https://www.ncbi.nlm.nih.gov/pubmed/30891886
http://dx.doi.org/10.1111/dom.13708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618254/
https://www.ncbi.nlm.nih.gov/pubmed/30891886
http://dx.doi.org/10.1111/dom.13708

Ejemplares similares